{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011472","form_type":"8-K","ticker":"OVID","cik":"0001636651","company_name":"Ovid Therapeutics Inc.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.579757+00:00","generated_at":"2026-06-25T02:46:33.187040+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Ovid Therapeutics annual meeting elects two directors, ratifies KPMG","bullets":["Annual meeting held June 9, 2022; 58.53% quorum (41,220,715 of 70,417,345 shares).","Kevin Fitzgerald elected: 23,339,939 for, 76,303 withheld; broker non-votes 17,804,473.","Bart Friedman elected: 17,204,205 for, 6,212,037 withheld; broker non-votes 17,804,473.","Ratification of KPMG as auditor for FY2022: 40,049,679 for, 1,157,936 against, 13,100 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011472","json":"https://secwatch.observer/filing/0000950170-22-011472.json","markdown":"https://secwatch.observer/filing/0000950170-22-011472.md","text":"https://secwatch.observer/filing/0000950170-22-011472.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636651/000095017022011472/0000950170-22-011472-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636651/000095017022011472/ovid-20220609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:46:33.187040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}